Submit Feedback
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Boston Scientific Corporation's Revenue by Segment

In fiscal year , Boston Scientific Corporation's revenue by segment (products & services) are as follows:


Learn more about Boston Scientific Corporation’s Revenue by Geography

Check out competitors to Boston Scientific Corporation in a side-by-side comparison.

Explore additional financial metrics for Boston Scientific Corporation.

Continue reading...

The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).

In fiscal year 2022, Boston Scientific Corporation's revenue by segment is as follows:

  • Cardiovascular generated $8.16B in revenue, representing 61.74% of its total revenue.
  • MedSurg generated $5.06B in revenue, representing 38.26% of its total revenue.

The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.74% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.26% of its total revenue.

The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).

In fiscal year 2023, Boston Scientific Corporation's revenue by segment is as follows:

  • Cardiovascular generated $8.82B in revenue, representing 61.93% of its total revenue.
  • MedSurg generated $5.42B in revenue, representing 38.07% of its total revenue.

The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.93% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.07% of its total revenue.
Continue reading...

Summary Table

Products & Services (Percent Share) 2022 2023 2024
Cardiovascular 61.74% 61.93% -
MedSurg 38.26% 38.07% -
Total Revenue 100% 100% 100%

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Cardiovascular revenue decreased -100% ($8.82B) from $8.82B (in 2023) to $0.00 (in 2024).
  • MedSurg revenue decreased -100% ($5.42B) from $5.42B (in 2023) to $0.00 (in 2024).
  • Continue reading...

    Summary Table

    Products & Services 2022 2023 2024
    Cardiovascular $8.16B - $8.82B
    8.06%
    - -
    MedSurg $5.06B - $5.42B
    7.22%
    - -
    Total Revenue $13.22B - $14.24B
    7.74%
    -
    100.00%